BOB RICE

Managing Director

Bob Rice began his career as a trial lawyer with the U.S. Department of Justice and then served as a tax, ERISA, and financial products Partner at Milbank for a decade.  He left the law to found a technology startup that became the public company Viewpoint, of which he was CEO and Chairman until he returned to Wall Street to launch Tangent in 2007.

In addition to his role at Tangent, Bob is a Senior Advisor for Macquarie Asset Management and Wilshire Associates; a member of the Board of Nasdaq Fund Secondaries; and an adjunct Law Professor at FSU,  teaching investment management courses with a focus on alternative investment vehicles and strategies. He is also a Director of the Value Line funds’ investment manager and  a member of the Florida State University Endowment Investment Committee, in which roles he helps oversee approximately $6 billion of AUM. 

Previously, Bob spent several years as a the daily on-air Alternatives Editor at Bloomberg TV and Fox Business; and he is the bestselling author of Three Moves Ahead and The Alternative Answer. Check the background of this investment professional on FINRA’s BrokerCheck.

THOMAS MAHONEY

Managing Director

Tom Mahoney has over 30 years of experience in the alternative investments industry and has raised over $7 billion for hedge funds, private equity funds and corporate private equity financings since 1985.

In addition to leading several global hedge fund and private equity investment banking teams at major Wall Street firms, most recently Tom served as Managing Director with Compass Advisers Group, LLC and earlier served as Chief Operating Officer, Chief Risk Officer and Head of Alternative Investments with Gabelli & Partners, a subsidiary of Gabelli Asset Management. At Gabelli, he was instrumental in the launch of several new hedge funds with global institutional investors (proprietary single and multi-strategy funds, separate accounts and offshore fund of funds) as well as a doubling of alternative assets under management to over $1 billion. Prior to Gabelli, during a ten-year tenure with Merrill Lynch, Tom created the firm's global hedge fund capital raising business as well as the industry-leading preferred stock capital markets franchise. Tom subsequently led Deutsche Bank’s industry pre-eminent technology private equity financing business, while also raising private equity funds and structuring strategy-diversified hedge fund portfolios for non-U.S. institutional investors. Tom also founded PaineWebber’s Private Equity Group and was a member of the Investment Committee for an investment partnership for Investment Banking Division employees. He started his career in international M&A at Dillon Read. Tom is an Advisory Board member of StratiFi Technologies Inc., a financial services focused software developer.

Mr. Mahoney earned an A.B. degree in chemistry from Harvard College and an M.B.A. from the Wharton School at the University of Pennsylvania, and was a Research Fellow in Synthetic Organic Chemistry at MIT. He holds Series 7, 24, 63 and 79 FINRA securities licenses. Check the background of this investment professional on FINRA’s BrokerCheck.

GARY WANG

Gary Wang is the head of Tangent’s China Desk and the co-founder and Managing Partner of Jade Capital Management, a principal investment company with strong focus on China. Mr. Wang was one of the founding members of China Rapid Finance, a Chinese financial technology company listed on NYSE in 2017. He was also one of the founding members of Quanta Capital, a Bermuda based insurance and reinsurance company listed on NASDAQ in 2004.  Mr. Wang was formerly the head of Credit Derivatives of Barclays Capital Asia.  He started his career as a quantitative analyst at Wells Fargo Bank and subsequently an options trader of Barclays Capital in New York. He has a BSc in Physics from Peking University and a Ph.D. in Physics from the University of California, San Diego. 

Rob Cunjak

Rob Cunjak has 25 years of business experience ranging from investment management to capital markets to strategy consulting. At Tangent, he is focusing on raising debt and equity capital for corporate issuers across industries in a variety of situations including early-stage ventures, growth equity, acquisition financings and recapitalizations. In addition, he is focusing on private placements for institutional managers across asset classes and real estate transactions. Over the years, Rob has developed a strong network of relationships across the institutional investor spectrum, such as alternative investment managers, endowments, foundations and family offices, among others, which he relies upon for creating capital solutions for clients.

Prior to joining Tangent Capital, Rob was a Managing Partner at Wren Capital, where he helped real estate and credit managers raise capital. Before Wren, he served in a variety of roles at Sankaty Advisors (now Bain Capital Credit) until his departure at the end of 2015: Managing Director (from January 2011), Portfolio Manager (from August 2010) and Head of Sankaty’s Energy Team (from 2009). He and his team invested billions of dollars and evaluated hundreds of syndicated and bespoke opportunities. They also built an extensive industry network which resulted in strong diligence and sourcing capabilities. In addition to his investment responsibilities, Rob was Co-Head of Sankaty’s Global Industry Research Team from 2009 through early 2014.

He was on the board of EnVen Energy Corporation and, prior to that, its predecessor, EnVen Energy Ventures from July 2014 to December 2016. Before joining Sankaty in September 1999, Rob was a Senior Associate Consultant at Bain & Co. which he joined in 1996.

Rob graduated with an MBA from Harvard Business School in 2003 and a BA from Cornell University in 1996. He currently holds FINRA licenses Series 63 and 82. Check the background of this investment professional on FINRA’s BrokerCheck.

Vishal Jain

Vishal Jain has extensive investment banking and consulting experience in many industries including pharma, biotech, and technology. He has gained an in-depth knowledge of the complex healthcare ecosystem in the United States and has worked on transactions across multiple sub-sectors of healthcare including large pharma, biotechnology, diagnostics, healthcare instruments and devices, healthcare services and healthcare IT. Vishal has a keen interest in identifying innovative solutions for businesses and homes using combination of technology, healthcare, life sciences and Internet of things (IoT).

Vishal has raised over $100 billion in debt and equity capital and has provided strategic advice to large as well as small corporations with respect to M&A, public offerings & capital markets, divestitures and spin-offs. He is a Partner at Freyeur & Trogue, which is a strategic partner of Tangent in the life science and technology capital raising space. Additionally, he serves as the Chairman of the Board for Ansella Therapeutics. Prior to his current roles, he was a senior investment banker at Mizuho Securities and UBS Investment Bank.

Vishal has a degree in Electronics Engineering from the prestigious NIT in India and an MBA from Cornell University. Check the background of this investment professional on FINRA’s BrokerCheck.

Gary Kaufman

Gary Kaufman is a member of Tangent’s market client coverage group covering banks and asset managers for fixed income investment advisory services and fund raising. Prior to joining Tangent, he was a Managing Director at UBS where he was head of Fixed Income Rates Sales. Previously, he was a VP at Deutsche Bank and Bankers Trust in fixed income derivative sales.

Gary earned a MBA in Finance from NYU and a BA in Computer Science from Yeshiva University. Check the background of this investment professional on FINRA’s BrokerCheck.